Andrew Groves | University of Iowa Clinical Research and Trials

Attention Site Visitor

You are currently visiting the UI Health Care Clinical Trials website on a version of the web browser: Internet Explorer. Internet Explorer is no longer being supported by Microsoft, and there are features and functionality on this website that does not operate properly when using Internet Explorer. If you have an alternative browser, such as: Microsoft Edge, Google Chrome, Mozilla Firefox, or Apple Safari, we suggest you switch to that browser for the optimal viewing experience.

Thank you

Studies

Phase 1 trial of intrathecal azacitidine and nivolumab in patients with recurrent high-grade glioma

Cancer Pediatrics Brain and Spinal Cord Cancer Pediatric Subjects Adult Subjects Female Subjects Male Subjects

This is a single-arm open-label phase 1 dose escalation/expansion trial assessing the safety and efficacy of concurrent intrathecal azacitidine and intrathecal nivolumab in recurrent high-grade glioma.

Pharmacogenomic Testing in Children and Young Adults Receiving Care in the Pediatric Hematology/Oncology Clinic at the University of Iowa

Cancer Pediatrics Pediatric Subjects Adult Subjects Female Subjects Male Subjects